Table 1 Baseline characteristics according to TyG groups
Characteristics | Total n = 2719 | Tertile1* n = 906 | Tertile2 n = 907 | Tertile3 n = 906 | P value |
|---|---|---|---|---|---|
Age(years) | 60.9 ± 6.6 | 61.3 ± 6.7 | 60.9 ± 6.6 | 60.5 ± 6.4 | 0.04 |
Female (n, %) | 1441(53.0) | 465(51.3) | 498(54.9) | 478(52.8) | 0.31 |
Current smoking, n (%) | 566(20.8) | 184(20.3) | 193(21.3) | 189(20.9) | 0.88 |
Current drinking, n (%) | 522(19.2) | 170(18.8) | 171(18.9) | 181(20.0) | 0.77 |
History of comorbidities (n, %) | Â | Â | Â | Â | Â |
Hypertension | 1095(40.3) | 270(29.8) | 364(40.1) | 461(50.9) | < 0.001 |
Dyslipidemia | 533(19.6) | 77(8.5) | 174(19.2) | 282(31.3) | < 0.001 |
TIA | 9(0.3) | 2(0.2) | 6(0.7) | 1(0.1) | 0.10 |
Stroke | 64(2.4) | 24(2.7) | 19(2.1) | 21(2.3) | 0.74 |
Coronary artery disease | 10(0.4) | 4(0.4) | 3(0.3) | 3(0.3) | 0.90 |
Medication history (n, %) | Â | Â | Â | Â | Â |
Lipid-lowering medicine | 90(3.3) | 16(1.8) | 38(4.2) | 36(4.0) | < 0.001 |
Statins | 82(3.0) | 16(1.8) | 35(3.9) | 31(3.4) | 0.02 |
Fibrate | 5(0.2) | 0(0.0) | 2(0.2) | 3(0.3) | 0.23 |
Other | 4(0.2) | 0(0.0) | 1(0.1) | 3(0.3) | 0.17 |
Antihypertensive medications | 667(24.5) | 152(16.8) | 211(23.3) | 304(33.6) | < 0.001 |
BMI (km/m2) | 23.7 ± 2.0 | 22.4 ± 2.9 | 23.9 ± 2.9 | 24.7 ± 2.8 | < 0.001 |
FPG (mmol/L) | 5.66 ± 0.98 | 5.4 ± 0.5 | 5.6 ± 0.7 | 6.0 ± 1.4 | < 0.001 |
Fasting insulin (mmol/L) | 6.2(4.4–8.8) | 4.8(3.4–6.5) | 6.2(4.6–8.7) | 8.1(5.9–10.9) | < 0.001 |
TG (mg/ dL) | 1.7 ± 1.2 | 0.9 ± 0.2 | 1.5 ± 0.2 | 2.9 ± 1.4 | < 0.001 |
eGFR (mL/min/1.73 m2) | 102.3 ± 11.7 | 103.2 ± 10.8 | 101.6 ± 12.3 | 102.1 ± 12.0 | 0.02 |
LDL (mmol/L) | 2.8 ± 0.8 | 2.6 ± 0.7 | 3.0 ± 0.8 | 2.8 ± 0.9 | < 0.001 |